Chief executive officer László Puskás, PhD, DSc Dr. Puskás received a Master Degree in Biology (1994) and a PhD in chemistry (1997) at the Medical
CANCER – Avinomid (Ac-2010) Researchers at Avidin have synthesized analogues of novel Immune Modulatory Drugs (IMIDs) which may have benefits over the current treatments for
Non-GLP toxicology, inflammationand cancer models Avidin is providing services for acute and sub-chronic toxicology of drug candidates in rats and mice and performs POC studies
IVIS® imaging technology (Xenogen/Caliper, USA) provides the most sensitive systems available – for both fluorescence and bioluminescence imaging. IVIS molecular imaging systems are designed to
Avidin has established multiple in vivo assay systems to evaluate novel anti-cancer compounds. Our services include subcutaneous xenograft, orthotopic and syngeneic models and Maximum Tolerated
A) In vitro toxicology on cell cultures Avidin has more than 50 cell lines as well as primer neuronal cell cultures to test cytotoxicity of
Dr. Puskás received a Master Degree in Biology (1994) and a PhD in chemistry (1997) at the Medical Faculty of the University of Szeged, Hungary.